Drawing for QUANTUMPACK

USPTO serial 79300858

QUANTUMPACK

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
Examiner
STADELI, MARTA ANN
Law office
TMO LAW OFFICE 123

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QUANTUMPACK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations in the form of luminous particles containing quantum dots for industrial purposes; in vitro diagnostic reagents containing quantum dots for scientific purposes; chemical preparations in the form of semiconductor nanocrystal particles containing quantum dots for fluorescent biolabeling; chemical preparations for fluorescence emission containing quantum dot nanoparticles with semiconductor propertiesACTIVE
005In vitro diagnostic preparations containing quantum dots for medical purposes; diagnostic reagents containing quantum dots for medical purposesACTIVE
009Biosensors for sensing radiation, light, electricity, gases, liquids, solids or air; diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for the detection of proteins, antigens, and antibodies for laboratory and research use; sensors for measuring light intensity and chemical identity, other than for medical use; downloadable and recorded computer software for diagnosing diseases for medical purposes; electrochemical gas sensorsACTIVE
010Medical diagnostic apparatus equipped with quantum dots for diagnosing heart and inflammatory disease, cancer, and infectious disease; Measuring instruments for medical purposes equipped with quantum dots, namely, medical instruments for measuring a level of specific protein, antigen, and antibody in a sample; test equipment for medical use equipped with quantum dots, namely, blood testing apparatus, medical diagnostic apparatus for testing a level of specific protein, antigen, and antibody in a sample; blood analysis apparatus for diagnosis equipped with quantum dots; body fluid analysis apparatus equipped with quantum dots, namely, medical diagnostic instruments for the analysis of body fluids; in vitro diagnostic devices for medical purposes equipped with quantum dots, namely, diagnostic apparatus for diagnosing heart and inflammatory disease, cancer, and infectious disease; blood testing apparatus equipped with quantum dots; blood analysis equipment equipped with quantum dots; apparatus for blood analysis equipped with quantum dotsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 24, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 26, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 13, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 12, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 3, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 13, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 20, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 19, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 23, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 12, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 25, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 25, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 17, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 24, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 17, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 17, 2021GNSLLETTER OF SUSPENSION E-MAILED
Aug 17, 2021CNSLSUSPENSION LETTER WRITTEN
Aug 4, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 4, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 11, 2021RFNTREFUSAL PROCESSED BY IB
Apr 21, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 21, 2021RFRRREFUSAL PROCESSED BY MPU
Apr 20, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 19, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 8, 2021DOCKASSIGNED TO EXAMINER
Jan 1, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Dec 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 24, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance